Chemotherapeutic implications of polyamine biosynthesis inhibition.

Clinical pharmacology and therapeutics ·Vol. 35 ·No. 3 ·1984-03-00 ·Pages 287-300

Sjoerdsma A, Schechter PJ

Abstract

暂无摘要

MeSH Terms

Animals Drug Evaluation Eflornithine Female Humans Male Melanoma/drug therapy Mice Middle Aged Ornithine/analogs & derivatives,therapeutic use Ornithine Decarboxylase Inhibitors Polyamines/biosynthesis Protozoan Infections/drug therapy Trypanosomiasis, African/drug therapy

Chemicals

Ornithine Decarboxylase Inhibitors Polyamines Ornithine Eflornithine

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Sjoerdsma A

Schechter P J

Article Info

Journal

Clinical pharmacology and therapeutics

Abbr.

Clin Pharmacol Ther

ISSN

0009-9236

DOI

10.1038/clpt.1984.33

Published

1984-03-00

Pages

287-300

Language

English

Region

United States

NLM ID

0372741

Subset

External Links

PubMed source DOI: 10.1038/clpt.1984.33 View journal details

Analysis Services

Chemotherapeutic implications of polyamine biosynthesis inhibition.

Contact

WeChat Official Account